治療用血漿交換の世界市場レポート 2025年

治療用血漿交換市場規模は、今後数年間で力強い成長が見込まれます。2029年にはCAGR9.5％で23億2,000万米ドルに成長します。予測期間の成長は、高齢者人口の増加、臨床エビデンスとガイドライン、規制環境、病院インフラとヘルスケア投資、ヘルスケア支出、償還政策に起因すると考えられます。予測期間における主な動向には、個別化治療、自動化の統合、共同イニシアチブ、遠隔医療統合などがあります。

血液疾患の有病率の増加は、今後の治療用血漿交換市場の拡大を牽引する見通しです。血液疾患（血液障害）には、血液や骨髄、リンパ節、脾臓などの造血組織に影響を及ぼす病状が含まれます。これらの疾患の増加は、遺伝的素因、環境の影響、ライフスタイルの変化などの要因によるものです。治療用血漿交換（TPE）は、自己免疫性溶血性貧血における自己抗体や血栓性血小板減少性紫斑病における免疫複合体のような血漿中の病原性物質を除去することにより、疾患の重症度を緩和し、患者の予後を改善することにより、血液疾患の管理に使用されます。例えば、2023年8月、米国の専門機関である白血病リンパ腫協会によると、骨髄腫の診断件数は2021年から2023年にかけて約2.3％増加し、それぞれ34,920件から35,730件になると予測されています。したがって、血液疾患の有病率の高さが治療用血漿交換市場の成長を後押ししています。

2022年7月、米国のテクノロジー企業であるテルモ・ブラッド・アンド・セル・テクノロジーズ社は、炎症性疾患や腎臓関連疾患の治療用アフェレシスに特化した米国の医療機器企業であるエリアズ・セラピューティクス社と戦略的提携を結びました。この提携は、血漿から炎症性タンパク質Gal-3を選択的に除去することにより、急性腎障害（AKI）および敗血症誘発性AKI（S-AKI）に対処することに焦点を当てています。この提携は、テルモのSpectra OptiaアフェレーシスシステムとEliaz Therapeutics社のXGal-3カラムを用いた新規治療の探求を目的としています。AKIに伴う死亡率の高さを考慮し、このパートナーシップの初期研究は、ヒト臨床試験に進む前に、大型動物で実施される予定です。テルモは治療的アフェレシスにおける専門知識で知られており、これまでにトリプルネガティブ乳がんやCOVID-19などの疾患を対象としたプロジェクトで共同研究を行ってきました。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場- 金利、インフレ、地政学、新型コロナウイルス感染症、そして景気回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界治療用血漿交換PESTEL分析（政治、社会、技術、環境、法的要因、促進要因と抑制要因）
• 最終用途産業の分析
• 世界の治療用血漿交換市場：成長率分析
• 世界の治療用血漿交換市場の実績：規模と成長, 2019-2024
• 世界の治療用血漿交換市場の予測：規模と成長, 2024-2029, 2034F
• 世界治療用血漿交換総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界の治療用血漿交換市場：タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 治療用血漿交換（TPE）
• 二重濾過血漿交換（DFPP）
• 世界の治療用血漿交換市場：適応症別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 神経疾患
• 血液疾患
• 腎疾患
• 代謝障害
• その他の適応症
• 世界の治療用血漿交換市場：技術別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 遠心分離
• 膜分離
• 世界の治療用血漿交換市場：エンドユーザー別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 血液採取センター
• 病院と診療所
• 輸血センター
• その他のエンドユーザー
• 世界の治療用血漿交換市場、治療用血漿交換（TPE）のサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• マニュアルTPE
• 自動化TPE
• 世界の治療用血漿交換市場二重濾過血漿交換（DFPP）の種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• シングルステージDFPP
• 多段DFPP

第7章 地域別・国別分析

• 世界の治療用血漿交換市場：地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 世界の治療用血漿交換市場：国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• 治療用血漿交換市場：競合情勢
• 治療用血漿交換市場：企業プロファイル
  • Medica S.p.A. Overview, Products and Services, Strategy and Financial Analysis
  • Fresenius SE and Co. KGaA Overview, Products and Services, Strategy and Financial Analysis
  • Medtronic Plc. Overview, Products and Services, Strategy and Financial Analysis
  • Asahi Kasei Corporation Overview, Products and Services, Strategy and Financial Analysis
  • Toray Industries Inc. Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• Baxter International Inc.
• B Braun Melsungen AG
• Terumo Corporation
• Kaneka Corporation
• Charles River Laboratories
• Octapharma AG
• Spectral Medical Inc.
• Nikkiso Co. Ltd.
• Haemonetics Corporation
• Miltenyi Biotec Technology And Trading Co. Ltd.
• Macopharma SA
• Cerus Corporation
• Apellis Pharmaceuticals Inc.
• ImmunoTek Bio Centers LLC
• CytoSorbents Corporation

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• 治療用血漿交換市場2029：新たな機会を提供する国
• 治療用血漿交換市場2029：新たな機会を提供するセグメント
• 治療用血漿交換市場2029：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

Therapeutic plasma exchange (TPE) is a medical intervention utilized in the treatment of specific autoimmune diseases and other medical conditions. In this procedure, blood is extracted from the body, the plasma component (the fluid part of blood) is separated from the blood cells, and the blood cells are subsequently reintroduced into the body, often after being mixed with a replacement fluid. This method aids in eliminating harmful substances from the bloodstream, such as autoantibodies or toxins, which are implicated in various diseases.

The primary modalities of therapeutic plasma exchange include therapeutic plasma exchange (TPE) and double-filtered plasmapheresis (DFPP). Therapeutic Plasma Exchange (TPE) is a clinical process that involves removing plasma from the blood and substituting it with a replacement fluid, facilitating the elimination of detrimental substances or excess components. This procedure finds application in diverse medical conditions such as neurological disorders, hematological disorders, renal disorders, metabolic disorders, among others. Various technologies, including centrifugation and membrane separation, are employed in this process, catering to a range of end users such as blood collection centers, hospitals and clinics, transfusion centers, and others.

The therapeutic plasma exchange market research report is one of a series of new reports from The Business Research Company that provides therapeutic plasma exchange market statistics, including therapeutic plasma exchange industry global market size, regional shares, competitors with a therapeutic plasma exchange market share, detailed therapeutic plasma exchange market segments, market trends and opportunities, and any further data you may need to thrive in the therapeutic plasma exchange industry. This therapeutic plasma exchange market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The therapeutic plasma exchange market size has grown strongly in recent years. It will grow from $1.47 billion in 2024 to $1.62 billion in 2025 at a compound annual growth rate (CAGR) of 9.8%. The growth in the historic period can be attributed to the emergence of immunological diseases, increasing technological advancements, increased awareness and education, expanded indications, and improved understanding of the pathophysiology.

The therapeutic plasma exchange market size is expected to see strong growth in the next few years. It will grow to $2.32 billion in 2029 at a compound annual growth rate (CAGR) of 9.5%. The growth in the forecast period can be attributed to the rising geriatric population, clinical evidence and guidelines, regulatory environment, hospital infrastructure and healthcare investments, healthcare expenditure, and reimbursement policies. Major trends in the forecast period include personalized therapies, integration of automation, collaborative initiatives, and telemedicine integration.

The increasing prevalence of hematological disorders is poised to drive the expansion of the therapeutic plasma exchange market in the future. Hematological disorders, or blood disorders, encompass medical conditions affecting blood and blood-forming tissues such as bone marrow, lymph nodes, and spleen. The rise in these disorders is attributed to factors such as genetic predispositions, environmental influences, and changes in lifestyle. Therapeutic plasma exchange (TPE) is employed in managing hematological disorders by removing pathogenic substances from the plasma, such as autoantibodies in autoimmune hemolytic anemia or immune complexes in thrombotic thrombocytopenic purpura, thus alleviating disease severity and enhancing patient outcomes. For example, in August 2023, as per the Leukemia and Lymphoma Society, a US-based professional organization, the projected number of myeloma diagnoses is expected to increase by approximately 2.3% from 2021 to 2023, rising from 34,920 to 35,730, respectively. Hence, the high prevalence of hematological disorders is fueling the growth of the therapeutic plasma exchange market.

In July 2022, Terumo Blood and Cell Technologies, a US-based technology company, formed a strategic partnership with Eliaz Therapeutics Inc., a US-based medical device company specializing in therapeutic apheresis for inflammatory and kidney-related conditions. This collaboration focuses on addressing acute kidney injury (AKI) and sepsis-induced AKI (S-AKI) by selectively removing the inflammatory protein Gal-3 from blood plasma. The partnership aims to explore novel treatments using Terumo's Spectra Optia Apheresis System and Eliaz Therapeutics' XGal-3 column. Given the high mortality rates associated with AKI, the partnership's initial studies will be conducted in large animals before progressing to human clinical trials. Terumo is known for its expertise in therapeutic apheresis and has previously collaborated on projects targeting conditions such as triple-negative breast cancer and COVID-19.

In July 2022, Discovery Life Sciences, Inc., a US-based provider of biospecimen analysis services, acquired AllCells for an undisclosed amount. This strategic acquisition aims to create a leading global provider of critical starting materials and analytic services, enhancing the development of cell and gene therapies (CGT) across the entire continuum-from discovery to commercialization. AllCells, a US-based company, specializes in providing clinical-grade and research-use primary cell products, including plasma exchange or plasmapheresis services. The acquisition is expected to strengthen Discovery Life Sciences' capabilities in supporting CGT development, positioning the company as a key player in the biotechnology and healthcare sectors.

Major companies operating in the therapeutic plasma exchange market are Medica S.p.A., Fresenius SE and Co. KGaA, Medtronic Plc., Asahi Kasei Corporation, Toray Industries Inc., Baxter International Inc., B Braun Melsungen AG, Terumo Corporation, Kaneka Corporation, Charles River Laboratories, Octapharma AG, Spectral Medical Inc., Nikkiso Co. Ltd., Haemonetics Corporation, Miltenyi Biotec Technology And Trading Co. Ltd., Macopharma SA, Cerus Corporation, Apellis Pharmaceuticals Inc., ImmunoTek Bio Centers LLC, CytoSorbents Corporation, Kawasumi Laboratories America Inc., Japan Medical Supply Co. Ltd.

North America was the largest region in the therapeutic plasma exchange market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the therapeutic plasma exchange market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the therapeutic plasma exchange market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The therapeutic plasma exchange market consists of revenues earned by entities by providing services such as patient evaluation, treatment planning, medical monitoring, and plasma separation. The market value includes the value of related goods sold by the service provider or included within the service offering. The therapeutic plasma exchange market also includes the sale of plasma separators, replacement fluids, anticoagulants, catheters and access devices, disposable consumables, and monitoring equipment. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Therapeutic Plasma Exchange Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on therapeutic plasma exchange market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for therapeutic plasma exchange ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The therapeutic plasma exchange market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Type: Therapeutic Plasma Exchange (TPE); Double Filtered Plasmapheresis (DFPP)
• 2) By Indication: Neurological Disorders; Hematological Disorders; Renal Disorders; Metabolic Disorders; Other Indications
• 3) By Technology: Centrifugation; Membrane Separation
• 4) By End User: Blood Collection Centers; Hospitals And Clinics; Transfusion Centers; Other End Users
• Subsegments:
• 1) By Therapeutic Plasma Exchange (Tpe): Manual Tpe; Automated Tpe
• 2) By Double Filtered Plasmapheresis (Dfpp): Single-Stage Dfpp; Multi-Stage Dfpp
• Companies Mentioned: Medica S.p.A.; Fresenius SE and Co. KGaA; Medtronic Plc.; Asahi Kasei Corporation; Toray Industries Inc.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Therapeutic Plasma Exchange Market Characteristics

3. Therapeutic Plasma Exchange Market Trends And Strategies

4. Therapeutic Plasma Exchange Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

5. Global Therapeutic Plasma Exchange Growth Analysis And Strategic Analysis Framework

• 5.1. Global Therapeutic Plasma Exchange PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Therapeutic Plasma Exchange Market Growth Rate Analysis
• 5.4. Global Therapeutic Plasma Exchange Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Therapeutic Plasma Exchange Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Therapeutic Plasma Exchange Total Addressable Market (TAM)

6. Therapeutic Plasma Exchange Market Segmentation

• 6.1. Global Therapeutic Plasma Exchange Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Therapeutic Plasma Exchange (TPE)
• Double Filtered Plasmapheresis (DFPP)
• 6.2. Global Therapeutic Plasma Exchange Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Neurological Disorders
• Hematological Disorders
• Renal Disorders
• Metabolic Disorders
• Other Indications
• 6.3. Global Therapeutic Plasma Exchange Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Centrifugation
• Membrane Separation
• 6.4. Global Therapeutic Plasma Exchange Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Blood Collection Centers
• Hospitals And Clinics
• Transfusion Centers
• Other End Users
• 6.5. Global Therapeutic Plasma Exchange Market, Sub-Segmentation Of Therapeutic Plasma Exchange (TPE), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Manual TPE
• Automated TPE
• 6.6. Global Therapeutic Plasma Exchange Market, Sub-Segmentation Of Double Filtered Plasmapheresis (DFPP), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Single-Stage DFPP
• Multi-Stage DFPP

7. Therapeutic Plasma Exchange Market Regional And Country Analysis

• 7.1. Global Therapeutic Plasma Exchange Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Therapeutic Plasma Exchange Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Therapeutic Plasma Exchange Market

• 8.1. Asia-Pacific Therapeutic Plasma Exchange Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Therapeutic Plasma Exchange Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Therapeutic Plasma Exchange Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Therapeutic Plasma Exchange Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Therapeutic Plasma Exchange Market

• 9.1. China Therapeutic Plasma Exchange Market Overview
• 9.2. China Therapeutic Plasma Exchange Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Therapeutic Plasma Exchange Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Therapeutic Plasma Exchange Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Therapeutic Plasma Exchange Market

• 10.1. India Therapeutic Plasma Exchange Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Therapeutic Plasma Exchange Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Therapeutic Plasma Exchange Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Therapeutic Plasma Exchange Market

• 11.1. Japan Therapeutic Plasma Exchange Market Overview
• 11.2. Japan Therapeutic Plasma Exchange Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Therapeutic Plasma Exchange Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Therapeutic Plasma Exchange Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Therapeutic Plasma Exchange Market

• 12.1. Australia Therapeutic Plasma Exchange Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Therapeutic Plasma Exchange Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Therapeutic Plasma Exchange Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Therapeutic Plasma Exchange Market

• 13.1. Indonesia Therapeutic Plasma Exchange Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Therapeutic Plasma Exchange Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Therapeutic Plasma Exchange Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Therapeutic Plasma Exchange Market

• 14.1. South Korea Therapeutic Plasma Exchange Market Overview
• 14.2. South Korea Therapeutic Plasma Exchange Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Therapeutic Plasma Exchange Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Therapeutic Plasma Exchange Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Therapeutic Plasma Exchange Market

• 15.1. Western Europe Therapeutic Plasma Exchange Market Overview
• 15.2. Western Europe Therapeutic Plasma Exchange Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Therapeutic Plasma Exchange Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Therapeutic Plasma Exchange Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Therapeutic Plasma Exchange Market

• 16.1. UK Therapeutic Plasma Exchange Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Therapeutic Plasma Exchange Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Therapeutic Plasma Exchange Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Therapeutic Plasma Exchange Market

• 17.1. Germany Therapeutic Plasma Exchange Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Therapeutic Plasma Exchange Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Therapeutic Plasma Exchange Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Therapeutic Plasma Exchange Market

• 18.1. France Therapeutic Plasma Exchange Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Therapeutic Plasma Exchange Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Therapeutic Plasma Exchange Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Therapeutic Plasma Exchange Market

• 19.1. Italy Therapeutic Plasma Exchange Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Therapeutic Plasma Exchange Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Therapeutic Plasma Exchange Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Therapeutic Plasma Exchange Market

• 20.1. Spain Therapeutic Plasma Exchange Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Therapeutic Plasma Exchange Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Therapeutic Plasma Exchange Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Therapeutic Plasma Exchange Market

• 21.1. Eastern Europe Therapeutic Plasma Exchange Market Overview
• 21.2. Eastern Europe Therapeutic Plasma Exchange Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Therapeutic Plasma Exchange Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Therapeutic Plasma Exchange Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Therapeutic Plasma Exchange Market

• 22.1. Russia Therapeutic Plasma Exchange Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Therapeutic Plasma Exchange Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Therapeutic Plasma Exchange Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Therapeutic Plasma Exchange Market

• 23.1. North America Therapeutic Plasma Exchange Market Overview
• 23.2. North America Therapeutic Plasma Exchange Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Therapeutic Plasma Exchange Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Therapeutic Plasma Exchange Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Therapeutic Plasma Exchange Market

• 24.1. USA Therapeutic Plasma Exchange Market Overview
• 24.2. USA Therapeutic Plasma Exchange Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Therapeutic Plasma Exchange Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Therapeutic Plasma Exchange Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Therapeutic Plasma Exchange Market

• 25.1. Canada Therapeutic Plasma Exchange Market Overview
• 25.2. Canada Therapeutic Plasma Exchange Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Therapeutic Plasma Exchange Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Therapeutic Plasma Exchange Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Therapeutic Plasma Exchange Market

• 26.1. South America Therapeutic Plasma Exchange Market Overview
• 26.2. South America Therapeutic Plasma Exchange Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Therapeutic Plasma Exchange Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Therapeutic Plasma Exchange Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Therapeutic Plasma Exchange Market

• 27.1. Brazil Therapeutic Plasma Exchange Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Therapeutic Plasma Exchange Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Therapeutic Plasma Exchange Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Therapeutic Plasma Exchange Market

• 28.1. Middle East Therapeutic Plasma Exchange Market Overview
• 28.2. Middle East Therapeutic Plasma Exchange Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Therapeutic Plasma Exchange Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Therapeutic Plasma Exchange Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Therapeutic Plasma Exchange Market

• 29.1. Africa Therapeutic Plasma Exchange Market Overview
• 29.2. Africa Therapeutic Plasma Exchange Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Therapeutic Plasma Exchange Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Therapeutic Plasma Exchange Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Therapeutic Plasma Exchange Market Competitive Landscape And Company Profiles

• 30.1. Therapeutic Plasma Exchange Market Competitive Landscape
• 30.2. Therapeutic Plasma Exchange Market Company Profiles
  • 30.2.1. Medica S.p.A. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Fresenius SE and Co. KGaA Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Medtronic Plc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Asahi Kasei Corporation Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Toray Industries Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Therapeutic Plasma Exchange Market Other Major And Innovative Companies

• 31.1. Baxter International Inc.
• 31.2. B Braun Melsungen AG
• 31.3. Terumo Corporation
• 31.4. Kaneka Corporation
• 31.5. Charles River Laboratories
• 31.6. Octapharma AG
• 31.7. Spectral Medical Inc.
• 31.8. Nikkiso Co. Ltd.
• 31.9. Haemonetics Corporation
• 31.10. Miltenyi Biotec Technology And Trading Co. Ltd.
• 31.11. Macopharma SA
• 31.12. Cerus Corporation
• 31.13. Apellis Pharmaceuticals Inc.
• 31.14. ImmunoTek Bio Centers LLC
• 31.15. CytoSorbents Corporation

32. Global Therapeutic Plasma Exchange Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Therapeutic Plasma Exchange Market

34. Recent Developments In The Therapeutic Plasma Exchange Market

35. Therapeutic Plasma Exchange Market High Potential Countries, Segments and Strategies

• 35.1 Therapeutic Plasma Exchange Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Therapeutic Plasma Exchange Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Therapeutic Plasma Exchange Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer